SAO PAULO, Brazil – Now working without the hurdle of a trade embargo, Cuba's largest biopharma group is forging ahead with renewed optimism about the future.
SAO PAULO, Brazil – Brazilian regulators should move quickly to improve the processes involved in clinical trials in the country, said industry stakeholders gathered for the annual BIO Latin America conference.
SAO PAULO, Brazil – Brazil's Butantan Institute is moving forward with the development of a Zika vaccine, which could be ready for the market by the end of next year or early 2018.
SAO PAULO, Brazil – A lackluster start for what is one of the largest annual biotech conferences in Latin America underscored the challenges to the industry in Brazil, a country struggling to recover from a series of political and economic reversals that have thrown the once promising economy into chaos.
BOGOTA, Colombia – Much of the discussion on the growth of Asian biotech companies is either on their efforts to expand in China or to gain more market share in Europe or North America, but companies are well aware that other markets may also provide interesting opportunities for growth.
BOGOTA, Colombia – As the Argentine biotech sector strengthens on the back of a pivotal leadership shift last year, local companies are looking to tap into international markets, especially countries that lack domestic biopharmaceutical manufacturing.
BOGOTA, Colombia – Much of the discussion on the growth of Asian biotech companies is either on their efforts to expand in China or their efforts to gain more market share in Europe or North America, but companies are well aware that other markets may also provide interesting opportunities for growth.
